News

Expanding Horizons: Standard Premium’s Surge to Forty States

Expanding Horizons: Standard Premium’s Surge to Forty States

Expansion Milestone for Standard Premium Finance

MIAMI -- Standard Premium Finance Holdings, Inc. (OTCQX: SPFX), a prominent player in specialty finance, is thrilled to announce its significant progress in national market presence. The company has successfully received new licensing approvals, now operating in a remarkable 40 states. This expansion comes on the heels of licensing achievements in various states, including New Jersey, New York, North Dakota, Pennsylvania, and Utah. These new states join those approved in 2024, such as Connecticut, Michigan, Rhode Island, and others, enhancing Standard Premium's footprint.

Commitment to Growth and Service

William Koppelmann, the CEO of Standard Premium, expresses pride in reaching this milestone, stating, "This accomplishment reflects our unwavering dedication to responsible growth while serving agents, carriers, and insureds nationwide." The company's recently expanded line of credit, now totaling $115 million, has more than doubled its capital availability, positioning Standard Premium to effectively pursue its geographic growth strategy.

A Disciplined Approach to Market Entry

Standard Premium’s continued expansion is a testament to its disciplined market entry strategies and compliance with regulations. By fostering solid relationships with state departments of insurance and investing in operational readiness, Standard Premium ensures a hassle-free onboarding experience for both agents and policyholders. This proactive approach not only facilitates successful market penetration but also significantly enhances customer satisfaction.

Strategic Vision for Long-term Success

According to Brian Krogol, CFO of Standard Premium, achieving approvals in 40 states is a pivotal step in their long-term growth strategy. "This broadened geographic reach not only expands our clientele but also fortifies our portfolio's diversification," he noted. With each new licensing achievement, Standard Premium positions itself as a more formidable competitor within the specialty finance sector.

Success through Innovation

The success of these initiatives is accompanied by a strong presence in leading trade publications throughout 2025, further solidifying Standard Premium’s role in the industry. The company’s commitment to innovation and efficient service delivery continues to attract attention and admiration from both clients and investors.

Enhancing Stakeholder Value

These licensing approvals are aligned with Standard Premium's broader initiatives to penetrate new markets and consistently deliver substantial value to all stakeholders involved. With a focus on versatility and adaptability, Standard Premium seeks to respond to the evolving needs of its diverse customer base while maintaining its high standards of excellence.

About Standard Premium Finance Holdings, Inc.

Standard Premium Finance Holdings, Inc. (OTCQX: SPFX), has been financing premiums for over $2 billion in property and casualty insurance policies since its inception in 1991. As a specialist in the field, it operates in various states and is actively seeking mergers and acquisitions of synergistic businesses that can leverage economies of scale and foster further growth.

Company Contact Information

For inquiries, you can reach out to: Nicholas Turchiano at CPR Marketing, via email at nturchiano@cpronline.com or by calling 201-641-1911x35.

Frequently Asked Questions

What recent achievements has Standard Premium accomplished?

Standard Premium has recently received licensing approvals allowing it to operate in 40 states, solidifying its national presence in the specialty finance sector.

How has Standard Premium's financing capacity changed?

The company has expanded its line of credit to $115 million, more than doubling its availability of capital for growth initiatives.

What is the significance of the company's expansions?

Expanding to new states broadens the customer base and enhances the company's portfolio diversification, which is a crucial aspect of its long-term growth strategy.

How does Standard Premium ensure compliance in its operations?

The company maintains strong relationships with state insurance departments and continuously invests in operational readiness to facilitate smooth onboarding for agents and policyholders.

What role does innovation play at Standard Premium?

Innovation is central to Standard Premium's strategy, enabling the company to meet evolving market needs and deliver high-quality service effectively.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 222

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 288

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 202

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 162

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading

Top 5 Most Recently Viewed Articles

Alto Neuroscience, Inc. Faces Class Action Lawsuit Risk

Updated Category News Views 181

Class Action Lawsuit Against Alto Neuroscience, Inc. Alto Neuroscience, Inc. (NYSE: ANRO) is currently facing a class action lawsuit filed by a national shareholder rights litigation firm. This lawsuit revolves around allegations of securities fraud, claiming the company made misleading statements regarding the efficacy of its product ALTO-100 in treating major depressive...

Continue Reading
Hyatt and Playa Hotels Explore Strategic Partnership Options

Updated Category News Views 218

Hyatt Engages in Exclusive Discussions with Playa Hotels Hyatt Hotels (NYSE: H) is currently in exclusive negotiations regarding a potential takeover of Playa Hotels & Resorts (NASDAQ: PLYA) N.V. This engagement marks a significant move for both companies as they explore various strategic options for the $1.2 billion resort operator. The announcement has generated...

Continue Reading
LingoAce Celebrated as Top Innovator in Global Education Market

Updated Category News Views 111

LingoAce Celebrated as Top Innovator in Global Education Market Pioneering Tech-driven, Personalized Learning for over 580,000 Learners Worldwide LingoAce, a prominent global EdTech company, has received recognition as a 2025 Forbes China Influential Brand in Education. This honor was presented during the inaugural 2025 Forbes China Educational Industry Summit,...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 138

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
NV5 Global Backs Major Coastal Mapping Initiative in New Zealand

Updated Category News Views 197

NV5 Global Secures $4 Million Coastal Mapping Contract NV5 Global, Inc. (NASDAQ: NVEE), a significant player in the professional engineering field, has recently secured a noteworthy contract with Toit? Te Whenua Land Information New Zealand (LINZ) for a $4 million coastal mapping project. This contract is an important milestone in NV5's effort to expand its international...

Continue Reading